VISTAGEN THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Fair Value
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Adjustments to Additional Paid in Capital, Fair Value of $98.40 thousand for the 12-month period ending 2015-03-31, per its 10-K filed 2016-06-24.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket · last filed 2016-06-24
- VISTAGEN THERAPEUTICS, INC. adjustments to additional paid in capital, fair value for fiscal 2015 was $98.40K, a 51.84% decline from fiscal 2014.
- VISTAGEN THERAPEUTICS, INC. adjustments to additional paid in capital, fair value for fiscal 2014 was $204.30K.
| Period end | Adjustments to Additional Paid in Capital, Fair Value 12 month |
|---|---|
| 2015-03-31 | $98.40K 10-K · filed 2016-06-24 |
| 2014-03-31 | $204.30K 10-K · filed 2015-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |